In 2018, around 1.5 million people died from tuberculosis (TB) — an infectious disease that mainly affects the lungs. A major obstacle in the clinical treatment of TB is the long therapy time required to clear the infection. An infected patient needs to take antibiotics for over 6 to 9 months to prevent a relapse — a duration so long that many discontinue their medications.
Researchers from JNCASR have developed an innovative method to activate thermally activated delayed fluorescence (TADF) molecules, by trapping it with light in a “optical cavity”.
Bengaluru/ Jan 31, 2025